{"authors": [["de Toffol", "Bertrand", "B", "Inserm U 930, CHU Bretonneau, service de neurologie et neurophysiologie clinique, 2 bis, boulevard Tonnell\u00e9, 37044 Tours cedex, France. Electronic address: bertrand.detoffol@univ-tours.fr."], ["Hingray", "Coraline", "C", "Centre psychiatrique de Nancy, p\u00f4le universitaire du Grand-Nancy, 1, rue du Dr Archambault, 54520 Laxou, France."], ["Biberon", "Julien", "J", "CHU Bretonneau, service de neurologie et neurophysiologie clinique, 2 bis, boulevard Tonnell\u00e9, 37044 Tours cedex, France."], ["El-Hage", "Wissam", "W", "CHRU de Tours, clinique psychiatrique universitaire, 37044 Tours cedex, France."]], "date": "2017-12-20", "id": "29275022", "text": "Psychiatric comorbidities are overrepresented in people suffering from epilepsy in comparison to the general population. There is a two-way link between epilepsy and psychiatric disorders. Psychiatric symptomatology is specific in epilepsy, according to the chronology of symptoms in relation to the seizure (inter, pre- or postictal). Easy to use, fast and efficient self-administered questionnaires are available to evaluate depressive (NDDI-E) and generalized anxiety disorder (GAD-7) symptoms. Selective serotonin reuptake inhibitors (SSRIs) are not proconvulsant and can be safely used to treat depressive or anxious disorders.", "doi": "10.1016/j.lpm.2017.10.019", "title": "[Psychiatric comorbidities in epilepsy].", "journal": ["Presse medicale (Paris, France : 1983)", "Presse Med"]}